VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Tuesday, December 30, 2025
Stock Comparison
Bio-Rad Laboratories, Inc. vs S&P Global Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Bio-Rad Laboratories, Inc.
BIO · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Bio-Rad Laboratories, Inc.'s moat claims, evidence, and risks.
View BIO analysisS&P Global Inc.
SPGI · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into S&P Global Inc.'s moat claims, evidence, and risks.
View SPGI analysisComparison highlights
- Moat score gap: S&P Global Inc. leads (77 / 100 vs 61 / 100 for Bio-Rad Laboratories, Inc.).
- Segment focus: Bio-Rad Laboratories, Inc. has 2 segments (59.9% in Clinical Diagnostics); S&P Global Inc. has 5 segments (32.6% in S&P Global Market Intelligence).
- Moat breadth: Bio-Rad Laboratories, Inc. has 6 moat types across 3 domains; S&P Global Inc. has 9 across 5.
Primary market context
Bio-Rad Laboratories, Inc.
Clinical Diagnostics
In vitro diagnostics test systems, reagents/test kits, informatics, and clinical laboratory quality controls
Global
Hospital laboratories; diagnostic reference laboratories; transfusion laboratories; physician office laboratories
IVD OEM / installed-base consumables supplier (systems + kits + controls)
59.9%
S&P Global Inc.
S&P Global Market Intelligence
Financial market data, analytics, and workflow tools for institutions
Global
B2B (institutional investors, banks, insurers, corporates)
Data/analytics and workflow software provider
32.6%
Side-by-side metrics
Moat coverage
Shared moat types
Bio-Rad Laboratories, Inc. strengths
S&P Global Inc. strengths
Segment mix
Bio-Rad Laboratories, Inc. segments
Full profile >Life Science
Competitive
Clinical Diagnostics
Oligopoly
S&P Global Inc. segments
Full profile >S&P Global Market Intelligence
Oligopoly
S&P Global Ratings
Oligopoly
S&P Global Commodity Insights
Oligopoly
S&P Global Mobility
Competitive
S&P Dow Jones Indices
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.